Smruthi Organics has informed that the ‘Trading Window’ pursuant to the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons pursuant to Regulation 9(1) and schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) Regulations, 2018, will remain dosed with effect from 1st July, 2022 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the First quarter ended 30th June, 2022. All Insiders of the Company are requested to take note of this intimation and not to deal with/ purchase or sale of the Company's securities during the Window Closure period.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |